Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.38 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.37 |
| ▸ | METAP2 | P50579 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27607757 | 0.83 | KDM4E (0.59) | KDM4EL3MBTL1HTTTSHRALDH1A1 | |
| SCHEMBL27508874 | 0.83 | CYP3A4 (0.39) | KDM4EALDH1A1CYP3A4CHRM1ALOX15 | |
| SCHEMBL1311974 | 0.80 | KDM4E (0.45) | KDM4EL3MBTL1HTTTSHRALDH1A1 | |
| SCHEMBL8747647 | 0.78 | ALDH1A1 (0.45) | KDM4EL3MBTL1ALDH1A1MAPTCYP3A4 | |
| SCHEMBL28501367 | 0.78 | KDM4E (0.44) | KDM4EL3MBTL1ALDH1A1MAPTLMNA | |
| SCHEMBL26120629 | 0.78 | PTGS2 (0.44) | L3MBTL1HTTTSHRMAPTPOLB | |
| SCHEMBL34463681 | 0.77 | KDM4E (0.68) | KDM4EL3MBTL1HTTTSHRALDH1A1 | |
| SCHEMBL26596783 | 0.77 | KDM4E (0.40) | KDM4EL3MBTL1ALDH1A1MAPTALOX15 | |
| SCHEMBL29031614 | 0.75 | SELL (0.42) | KDM4EALDH1A1MAPTALOX15LMNA | |
| SCHEMBL28821783 | 0.74 | ALDH1A1 (0.53) | L3MBTL1HTTTSHRALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109134241-A | The industrial process of 3,5- dimethyl benzoyl chloride | 山东凯盛新材料股份有限公司 | 2019-01-04 | — | — | CN | disclosed |
| CN-105283439-B | The dibenzoylhydrazine of boracic | 英特瑞克斯顿股份有限公司 | 2018-02-02 | — | — | CN | disclosed |
| EP-1125913-B1 | Preparation of 3,5-bis-(trifluormethyl)-benzoylchlorid and novel benzoylhalides: 3,5-bis-(trihalomethyl)- and 3,5-dimethyl- | BAYER AG (DE) | 2003-04-09 | — | — | EP | disclosed |
| US-6420601-B2 | FREE RADICAL CHLORINATION; FLUORINATION WITH HYDROGEN FLUORIDE AND/OR ANTIMONY PENTAFLUORIDE; CONVERTING THE BENZOYL FLUORIDE TO CHLORIDE BY REACTING WITH SILICON TETRACHLORIDE IN LEWIS ACID; CHEMICAL INTERMEDIATES | BAYER AKTIENGESELLSCHAFT (DE) | 2002-07-16 | — | — | US | disclosed |
| EP-1125913-A1 | Preparation of 3,5-bis-(trifluormethyl)-benzoylchlorid and novel benzoylhalides: 3,5-bis-(trihalomethyl)- and 3,5-dimethyl- | BAYER AG (DE) | 2001-08-22 | — | — | EP | disclosed |
| US-20010014759-A1 | Free radical chlorination; fluorination with hydrogen fluoride and/or antimony pentafluoride; converting the benzoyl fluoride to chloride by reacting with silicon tetrachloride in lewis acid; chemical intermediates | LANXESS DEUTSCHLAND GMBH (DE) | 2001-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010014759-A1 | Free radical chlorination; fluorination with hydrogen fluoride and/or antimony pentafluoride; converting the benzoyl fluoride to chloride by reacting with silicon tetrachloride in lewis acid; chemical intermediates | SCLY, SSB, CLIC4 | KDM4E 2339/4885L3MBTL1 258/4885HTT 1629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.